ChemPro Innovations is a leading biotechnology company at the forefront of chemical proteomics, leveraging innovative technologies for groundbreaking drug lead compound screening and target discovery within cellular environments.With established collaborations with pharmaceutical research enterprises and academic institutions, we are dedicated to rapidly overcoming barriers in identifying disease targets that remain elusive to traditional drug development approaches.

Our Chemical Proteomics Screening Platform enables the discovery of novel binding pockets and ligands for endogenous target proteins within live cells, covering a vast array of over 10,000 proteins and 40,000 binding sites. Identifies biologically active molecules in disease-relevant cells or tissues, widely applied in drug target discovery, novel mechanism research, and off-target protein analysis.